tiprankstipranks
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
Top Insiders StocksTop Gainers/ Losers/ Active StocksMost Visited WebsitesDividend StocksAI StocksLargest Companies by Market Cap
ETFs
Top ETFs by Upside
New
Top ETFs by Smart ScoreTop Gainers/ Losers/ Active ETFs
Crypto
Bitcoin
Popular
Ethereum
Commodities
Gold
New
Options
Unusual Options Activity
Popular
Currency
EUR/USD
Pro Newsletters
Smart Investor
Popular
Research Tools
Stock ScreenerETF Screener
Popular
Trending StocksDaily Analyst RatingsCompare StocksCompare ETFsPenny Stock ScreenerTechnical Analysis ScreenerDaily Insider Trading Tracker
Calendars
Earnings CalendarDividend CalendarEconomic CalendarIPO CalendarStock SplitsStock BuybacksMarket Holidays
Calculators
Dividend CalculatorDividend Yield CalculatorOptions Profit Calculator
Economic Indicators
Inflation RateUnemployment Rate
Dividend CenterBest Dividend Stocks
Popular
Best High Yield Dividend StocksDividend AristocratsDividend Stock Comparison
New
Dividend CalculatorDividend Returns ComparisonDividend Calendar
My ExpertsTop AnalystsTop Financial BloggersTop-Performing Corporate InsidersTop Hedge Fund ManagersTop Research FirmsTop Individual Investors
Personal Finance CenterMortgagesLoansInvesting & RetirementSpending & Savings
Calculators
401k Retirement CalculatorMortgage Calculator
Popular
Compound Interest CalculatorDollar Cost Averaging
New
Student Loan CalculatorAuto Loan Calculator
Education
How To Use TipRanksTipRanks LabsWebinar CenterGlossaryFAQs
About Us
About TipRanksContact UsCareersReviewsMobile APP
Working with TipRanks
Enterprise SolutionsTop Online BrokersBecome an Affiliate
Follow Us
NewsTrendingPortfolio
TOOLS
Portfolio
Watchlist
Top Insiders Stocks
Popular
Top Stocks
Popular
Top ETFs
Top Smart Score Stocks
Popular
Earnings
STOCKS
SPY
QQQ
AAPL
NVDA
TSLA
AMZN
BABA
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
Top Insiders Stocks
Top Gainers/ Losers/ Active Stocks
Most Visited Websites
Dividend Stocks
AI Stocks
Largest Companies by Market Cap
ETFs
ETF Center
Top ETFs by Upside
New
Top ETFs by Smart Score
Top Gainers/ Losers/ Active ETFs
Options
Options Market Overview
Unusual Options Activity
Popular
Most Active Options
Options Volume Leaders
Commodities
Gold
New
Crypto
Crypto Center
Bitcoin
Popular
Ethereum
Currency
Currency Center
EUR/USD
Pro Newsletters
Smart Investor
Popular
Research Tools
Stock Screener
ETF Screener
Popular
Trending Stocks
Daily Analyst Ratings
Compare Stocks
Compare ETFs
Penny Stock Screener
Technical Analysis Screener
Daily Insider Trading Tracker
Calendars
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
Market Holidays
Economic Indicators
Economic Indicators Center
Inflation Rate
Unemployment Rate
Federal Funds Rate
Calculators
Dividend Calculator
Dividend Yield Calculator
Options Profit Calculator
Dollar Cost Averaging
New
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
News
Portfolio
Personal Finance Center
Mortgages
Loans
Investing & Retirement
Spending & Savings
Calculators
Compound Interest Calculator
New
Mortgage Calculator
Popular
Auto Loan Calculator
Student Loan Calculator
401k Retirement Calculator
Enterprise Solutions
Plans & Pricing
Education
How To Use TipRanks
TipRanks Labs
Webinar Center
Glossary
FAQs
About Us
About TipRanks
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Top Online Brokers
Become an Affiliate
Follow Us

PHAT Stock Latest News

Phathom Pharmaceuticals Announces FDA Approval of VOQUEZNA® (vonoprazan) Tablets for the Relief of Heartburn Associated with Non-Erosive GERD in Adults
Press ReleasesPhathom Pharmaceuticals Announces FDA Approval of VOQUEZNA® (vonoprazan) Tablets for the Relief of Heartburn Associated with Non-Erosive GERD in Adults
4d ago
PHAT
Phathom Pharmaceuticals announces FDA approval of VOQUEZNA
PremiumThe Fly
Phathom Pharmaceuticals announces FDA approval of VOQUEZNA
4d ago
PHAT
Biotech Alert: Searches spiking for these stocks today
PremiumThe Fly
Biotech Alert: Searches spiking for these stocks today
1M ago
TAK
AVTE
Phathom Pharmaceuticals to Participate in Upcoming Investor Conferences
PremiumPress Releases
Phathom Pharmaceuticals to Participate in Upcoming Investor Conferences
2M ago
PHAT
Phathom Pharmaceuticals to present VOQUEZNA data at DDW 2024
PremiumThe Fly
Phathom Pharmaceuticals to present VOQUEZNA data at DDW 2024
2M ago
PHAT
Phathom Pharmaceuticals sees cash runway through 2026
PremiumThe FlyPhathom Pharmaceuticals sees cash runway through 2026
2M ago
PHAT
Phathom Pharmaceuticals reports Q1 EPS ($1.42), consensus ($1.31)
PremiumThe Fly
Phathom Pharmaceuticals reports Q1 EPS ($1.42), consensus ($1.31)
2M ago
PHAT
Phathom Pharmaceuticals Reports First Quarter 2024 Financial Results and Provides Business Update
PremiumPress Releases
Phathom Pharmaceuticals Reports First Quarter 2024 Financial Results and Provides Business Update
2M ago
PHAT
Phathom Pharmaceuticals initiated with a Buy at Stifel
PremiumThe Fly
Phathom Pharmaceuticals initiated with a Buy at Stifel
3M ago
PHAT
Phathom Pharmaceuticals to Participate in the 23rd Annual Needham Virtual Healthcare Conference
PremiumPress Releases
Phathom Pharmaceuticals to Participate in the 23rd Annual Needham Virtual Healthcare Conference
4M ago
PHAT
Phathom Pharmaceuticals launches direct-to-consumer campaign
PremiumThe Fly
Phathom Pharmaceuticals launches direct-to-consumer campaign
4M ago
PHAT
Phathom Pharmaceuticals Launches Direct-to-Consumer Campaign, “VOQUEZNA Can Kick Some Acid”
PremiumPress Releases
Phathom Pharmaceuticals Launches Direct-to-Consumer Campaign, “VOQUEZNA Can Kick Some Acid”
4M ago
PHAT
Siga Technologies appoints Larry Miller as general counsel
PremiumThe FlySiga Technologies appoints Larry Miller as general counsel
4M ago
PHAT
SIGA
Short Report: Bearish positions reduced after contrasting C3.ai and Figs results
PremiumThe Fly
Short Report: Bearish positions reduced after contrasting C3.ai and Figs results
4M ago
AI
ATMU
Phathom Pharmaceuticals Reports Fourth Quarter and Full Year 2023 Financial Results and Provides Business Update
PremiumPress Releases
Phathom Pharmaceuticals Reports Fourth Quarter and Full Year 2023 Financial Results and Provides Business Update
5M ago
PHAT
Phathom Pharmaceuticals reports Q4 EPS ($1.39), consensus ($1.08)
PremiumThe Fly
Phathom Pharmaceuticals reports Q4 EPS ($1.39), consensus ($1.08)
5M ago
PHAT
Phathom Pharmaceuticals to Report Fourth Quarter and Full Year 2023 Financial Results and Provide Business Update on Thursday, March 7, 2024
PremiumPress Releases
Phathom Pharmaceuticals to Report Fourth Quarter and Full Year 2023 Financial Results and Provide Business Update on Thursday, March 7, 2024
5M ago
PHAT
Phathom Pharmaceuticals, Inc. (PHAT) Q4 Earnings Cheat Sheet
PremiumPre-Earnings
Phathom Pharmaceuticals, Inc. (PHAT) Q4 Earnings Cheat Sheet
5M ago
PHAT
Biotech Alert: Searches spiking for these stocks today
PremiumThe Fly
Biotech Alert: Searches spiking for these stocks today
5M ago
EQ
CLDX
Phathom announces VOQUEZNA tablets added to Express Scripts
PremiumThe FlyPhathom announces VOQUEZNA tablets added to Express Scripts
5M ago
PHAT
Phathom Pharmaceuticals’ VOQUEZNA Added to Express Scripts Formularies
PremiumCompany Announcements
Phathom Pharmaceuticals’ VOQUEZNA Added to Express Scripts Formularies
5M ago
8K
PHAT
Phathom Pharmaceuticals to Present at the Guggenheim Healthcare Talks 6th Annual Biotechnology Conference
PremiumPress Releases
Phathom Pharmaceuticals to Present at the Guggenheim Healthcare Talks 6th Annual Biotechnology Conference
6M ago
PHAT

Trending

Name
Price
Price Change
SPX
S&P 500
DJIA
Dow Jones
NDX
Nasdaq 100
More Trending Stocks >